pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

6,366 catalysts · 6,366 phase readout · 2,311 8k filing · 389 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 20 catalysts2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: patent expiry×clear all
type
  • phase readout6,366
  • 8k filing2,311
  • earnings389
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

16
›RECRUITINGphase readoutNCT07736651: Anti Inflammatory Diet With Physical Therapy on Psoriasis

Sponsor: Mahmoud Usama Mahmoud Ahmed. Phase: NA. Conditions: Psoriasis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07013929: Spyral InSight Study

Sponsor: Medtronic Vascular. Phase: NA. Conditions: Hypertension, Vascular Diseases, Cardiovascular Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT07452731: Effectiveness of a Mastery Learning Education Program for Parents of Children Using Inhaler Therapy in an Emergency Unit

Sponsor: Emine ŞAHİN. Phase: NA. Conditions: Shortness of Breath

full page →ctgov ↗
›COMPLETEDphase readoutNCT07708831: Trial on Single/Multiple Ascending Doses for Safety, PK and PD for CBP-0276 in Healthy Subjects

Sponsor: Clarent Biopharma, Inc.. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04692831: Testing a New Imaging Agent to Identify Cancer

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: HER-2 Positive Malignant Carcinoma of Breast, HER-2 Protein Overexpression, HER2-positive Metastatic Breast Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03612531: Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Cancer Survivor, Dysphagia, Fibrosis, Head and Neck Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06092502: Shoulder Impingement Syndrome and Graded Motor Imagery

Sponsor: Nuray Alaca. Phase: NA. Conditions: Shoulder Pain, Shoulder Impingement Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07445802: Medication Adherence in Severe Mental Illness: a Promotion Program

Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Phase: NA. Conditions: Treatment Adherence and Compliance, Severe Mental Disorders, Bipolar Disorder (BD), Schizophrenia Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07733453: Baerveldt Versus Paul Study

Sponsor: University of Sydney. Phase: PHASE4. Conditions: Glaucoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07158853: Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder

Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Opioid Use Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT07347353: Molecular HistoMx Assessment for Kidney Transplant Rejection and Management

Sponsor: Paris Translational Research Center for Organ Transplantation. Phase: . Conditions: Graft Rejection

full page →ctgov ↗
›RECRUITINGphase readoutNCT07386353: Intrathecal Versus Epidural Morphine for Post-Cesarean Analgesia

Sponsor: Hospital Central do Funchal. Phase: PHASE4. Conditions: Analgesia Obstetrical, Analgesia, Post Operative Pain, Patient Satisfaction, Cesarean Section Pain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07655453: Early Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of STR-P005

Sponsor: Starna Therapeutics. Phase: NA. Conditions: Relapsed/Refractory Autoimmune Diseases

full page →ctgov ↗
›COMPLETEDphase readoutNCT07757737: Impact of Exoskeleton Use on Perceived Effort and Pain During Resident Handling in Nursing Home Care Staff

Sponsor: LNA SANTE. Phase: . Conditions: Musculoskeletal Diseases, Occupational Diseases, Low Back Pain, Occupational Health

full page →ctgov ↗
›RECRUITINGphase readoutNCT06469437: The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM

Sponsor: Hospital de Clinicas de Porto Alegre. Phase: NA. Conditions: Type2diabetes, Frail Elderly Syndrome, Frailty, Geriatric Assessment

full page →ctgov ↗
›COMPLETEDphase readoutNCT03944837: Acute Maternal Hyperoxygenation in CHD

Sponsor: The Hospital for Sick Children. Phase: NA. Conditions: Congenital Heart Disease

full page →ctgov ↗
← prev
page 128 of 128
next →